From clinical-trial-simulation
Design group sequential trials with interim analyses, alpha spending, and futility stopping.
npx claudepluginhub choxos/biostatagent --plugin clinical-trial-simulation# Group Sequential Design Workflow ## Overview Design and simulate group sequential trials with interim analyses for early stopping due to efficacy or futility. ## Workflow Phases ### Phase 1: Design Specification <Task> subagent_type: gs-design-specialist prompt: | Specify group sequential design: 1. Number of analyses (interim + final) 2. Information fractions (timing of analyses) 3. Alpha spending function (OBF, Pocock, HSD) 4. Futility stopping rules (binding vs non-binding) 5. Integration with gsDesign2 (if applicable) 6. Stopping boundaries derivation </Task> ### P...
Design and simulate group sequential trials with interim analyses for early stopping due to efficacy or futility.
n_analyses: Number of analyses (default: 3)info_frac: Information fractions (default: evenly spaced)alpha_spending: "OBF", "Pocock", or list(sf=, param=)futility: TRUE/FALSE (default: TRUE)futility_binding: TRUE/FALSE (default: FALSE)n_sim_h1: Simulations under H1 (default: 10000)n_sim_h0: Simulations under H0 (default: 100000)